Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -24.8% | 138.9% | -51.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 15.5% | 19.7% | 21.8% | 15% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -23,548.4% | -7,246.1% | 32,697.5% | -48,700.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26,718.6% | -14,387.4% | -29,463.9% | -76,949.7% |
| EPS Diluted | 0 | -0.003 | -0.003 | -0.017 |
| % Growth | 100% | -17.2% | 82.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |